Why?
Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don t put up a paywall – we believe in free access to information of public interest.
Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more here
Why?
Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don t put up a paywall – we believe in free access to information of public interest.
Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more here
Date Time
Structural biology at EMBL: driving technology development
Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field, creating ingenious inventions with worldwide impact. First member of the MD3 diffractometer family installed at EMBL Hamburg. Credits: Kinga Lubowiecka/EMBL
Scientific breakthroughs are often only made possible by innovative technological developments. This is certainly true in structural biology, where researchers seek to gain insight into biological processes by determining the structure of macromolecules at the atomic level, for instance by X-ray crystallography or cryo-electron microscopy. Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field, creating ingenious inventions with worldwide impact.
EMBL alumnus transfers skills and experience to oversee starting materials for mRNA in vaccine manufacturing Now Manager of mRNA Starting Materials at BioNTech, alumnus Pawel Masiewicz credits his experiences at EMBL with leading him to this unique professional opportunity. Credit: Justyna Masiewicz
When Pawel Masiewicz was expanding his scientific knowledge about RNA molecules at EMBL and honing his skills as a project manager, he may have hoped these experiences would land him a position at a company aspiring to individualise cancer medicine. It turned out that his hope became reality and then some, as he now works for the company that made the first approved COVID-19 vaccine.